China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Rehabilitation nursing plan for rotator cuff injury based on behavior change theory'. T... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Transcranial Magnetic Stimulation in Patients with Chronic Subje... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of Risk Factors for Perioperative Anxiety and Construction and Validation of a... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Impact of image reconstruction methods on artificial intelligence image processing'... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Neuroendoscopy and Craniotomy on Postoperative Immune-Inflammation Trajector... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosi... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of "Triple-Low" Scanning Technique in Pulmonary Vein CT'. The following are... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Role of SENP3 in Regulating DRP1-mediated Mitochondrial Division in the Oc... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanistic Investigation of CD2AP-Mediated Extracellular Vesicle Biogenesis via Liquid... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, double-blind, parallel-controlled, dose-range Phase II clini... Read More